comparemela.com

Latest Breaking News On - Fruquintinib development - Page 1 : comparemela.com

HUTCHMED Receives Approval to Commercialize ELUNATE® in

First homegrown innovative medicine approved in Macau based on China clinical data.

Macau special administrative regionMacau generalUnited statesSouth koreaKaren atkinFruquintinib developmentDrug administrationBeigene ltdData monitoring committeeJournal of the american medical associationChinese society of clinical oncology annual meetingAmerican society of clinical oncology annual meetingJapanese pharmaceuticalsEuropean medicines agencyNational medical products administrationChina national reimbursement drug list

Investegate |Hutchmed China Ltd Announcements | Hutchmed China Ltd: Approval to Commercialize ELUNATE in Macau

Investegate announcements from Hutchmed China Ltd, Approval to Commercialize ELUNATE in Macau

Macau special administrative regionMacau generalUnited statesHong kongSouth koreaMark leeZhou yiAtholl tweedie freddy crossleyKaren atkinBen atwell alex shawAnnie chengAmerican society of clinical oncology annual meetingChinese society of clinical oncology annual meetingChina limitedJapanese pharmaceuticalsChina national reimbursement drug list

HUTCHMED Receives Approval to Commercialize ELUNATE® in Macau

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Macau special administrative regionMacau generalUnited statesHong kongSouth koreaMark leeZhou yiAtholl tweedie freddy crossleyKaren atkinBen atwell alex shawAnnie chengAmerican society of clinical oncology annual meetingChinese society of clinical oncology annual meetingChina limitedJapanese pharmaceuticalsChina national reimbursement drug list

Investegate |Hutchmed China Ltd Announcements | Hutchmed China Ltd: Phase Ib/II Trial of Fruquintinib & Tislelizumab

Investegate announcements from Hutchmed China Ltd, Phase Ib/II Trial of Fruquintinib & Tislelizumab

United statesHong kongMark leeZhou yiAtholl tweedie freddy crossleyBen atwell alex shawEli lillyAnnie chengChina limitedChina national medical products administrationJapanese pharmaceuticalsChina national reimbursement drug listStock exchange of hong kongFruquintinib developmentDrug administrationData monitoring committee

vimarsana © 2020. All Rights Reserved.